A Single-arm Safety Study of Transplantation Using Umbilical Cord Blood and Human Placental-derived Stem Cells From Partially Matched Related Donors in Persons With Certain Malignant Blood Diseases and Non-malignant Disorders

Status unconfirmed

Conditions studied: Hematologic Malignancies

In brief

To investigate the safety of partially matched related human placental-derived stem cells (HPDSC) administered in conjunction with umbilical cord blood (UCB) stem cells from the same donor in subjects with various malignant or nonmalignant disorders potentially curable with stem cell transplantation and to assess potential restoration of normal hematopoiesis and immune function in subjects with these disorders

Key facts

Study ID

NCT00596999

Run by

Celgene Corporation

People needed

6

Starts

2007-05-01

Expected to finish

2013-12-01

Last updated by the study team

2012-04-10

Who can join

Age: any, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• suitable UCB collected from partially or fully HLA matched related donor
• subject requires umbilical cord transplantation

You may not qualify if…

• any condition, including the presence of laboratory abnormalities, which places the subject at unacceptable risk if he/she were to participate in the study or confounds the ability to interpret data from the study
• major anticipated illness or organ failure incompatible with survival from stem cell transplant

Where it is running

• Louisiana State University Children's Hospital — New Orleans, Louisiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.